Investors are high on marijuana derivatives as cannabis stocks were mostly higher on Monday, after the US Food and Drug Administration said it is expediting its effort to create a regulatory framework for CBD with plans to publish a report on its progress by early fall.  Amy Abernathy, acting chief information officer, said in a series of tweets sent on Friday that the agency is “expediting its work to address the many questions about cannabidiol (CBD). This is an important national issue with p...